Nanobiosym partnered with SpaceX to send MRSA to the space station
Geplaatst: 11 feb 2024 17:09
Nanobiosym partnered with SpaceX to send MRSA to the space station
(I think this is it. I think this is the company they don't want anyone to investigate.)
https://x.com/FringeViews/status/175535 ... bzRdA&s=35
https://www.cbc.ca/radio/quirks/chewing ... -1.3988151
The pathogen known as MRSA -- methicillin-resistant staphylococcus aureus -- is lethal, and highly resistant to known antibiotics.
Now it's being sent into space by the nano-biotechnology company Nanobiosym. More precisely, Elon Musk's Falcon 9 rocket is going to carry it to the International Space Station. Once there, the pathogen will be subject to experiments designed to test the hypothesis that microgravity will accelerate the bug's mutation.
SpaceX sticks the landing and sticks it to the competition
How We'll Live on Mars
If it behaves as predicted, scientists could get a sneak preview of how the bug will behave down the line.
Nanobiosym's Chairperson, CEO and scientific director Dr. Anita Goel suggests that, ultimately, the findings from the research could be used to help drug development and find molecules that may be effective against MRSA strains that are predicted in the lab on the ISS.
(I think this is it. I think this is the company they don't want anyone to investigate.)
https://x.com/FringeViews/status/175535 ... bzRdA&s=35
https://www.cbc.ca/radio/quirks/chewing ... -1.3988151
The pathogen known as MRSA -- methicillin-resistant staphylococcus aureus -- is lethal, and highly resistant to known antibiotics.
Now it's being sent into space by the nano-biotechnology company Nanobiosym. More precisely, Elon Musk's Falcon 9 rocket is going to carry it to the International Space Station. Once there, the pathogen will be subject to experiments designed to test the hypothesis that microgravity will accelerate the bug's mutation.
SpaceX sticks the landing and sticks it to the competition
How We'll Live on Mars
If it behaves as predicted, scientists could get a sneak preview of how the bug will behave down the line.
Nanobiosym's Chairperson, CEO and scientific director Dr. Anita Goel suggests that, ultimately, the findings from the research could be used to help drug development and find molecules that may be effective against MRSA strains that are predicted in the lab on the ISS.